Connect with us

Technology

Zeto Announces Winners of Clinical Trial Sponsorship Program

Published

2 years ago

on

SANTA CLARA, Calif., June 25, 2024 /PRNewswire/ — Zeto, Inc., an award-winning medical technology firm, is proud to announce the winners of its 2024 Clinical Trial Sponsorship program. This initiative, announced at the 2023 Society for Neuroscience Convention in Washington D.C., invited research teams to submit proposals for clinical trials using the Zeto EEG device platform. The program aims to support advanced clinical research and to bring innovative applications closer to real-world implementation.

An expert jury panel, composed of professionals from the fields of neurology and neuroscience research, carefully reviewed all submissions and selected the winners based on several factors, including alignment with Zeto’s mission to enhance patient care through innovative EEG applications.

“The winners of the 2024 Clinical Trial Sponsorship program are conducting groundbreaking research aimed at improving patient care. These projects align perfectly with Zeto’s mission, and we are proud to support them. We look forward to continuing this sponsorship program annually,” said Florian Strelzyk, Chief Sales Officer at Zeto.

The winners of the 2024 Clinical Trial Sponsorship program are:

Efficacy of Portable EEG Technology in Pre-hospital Triage of Large Vessel Occlusion Strokes by Liqi Shu, MD and a multidisciplinary team from Brown University and Rhode Island Hospital, USA

This clinical trial will evaluate the Zeto EEG system’s ability to enhance pre-hospital triage of large vessel occlusion (LVO) strokes, aiming to significantly improve diagnostic speed and accuracy. By integrating Zeto’s advanced, portable EEG technology into EMS protocols, the study seeks to ensure rapid and appropriate routing of stroke patients to specialized care facilities, thereby optimizing treatment times and patient outcomes.

Gaze-independent visual brain computer interface for use by patients with limited to no eye control by Marc M. Van Hulle, Ph.D., and Arne Van Den Kerchove, Ph.D. from KU Leuven, Belgium

Brain computer interfaces (BCIs) have been serving paralyzed individuals by decoding their brain activity directly. A popular paradigm requires the patient to gaze at displayed targets but this is challenging for patients with limited to no eye control. Prof. Hulle’s team has developed a gaze-independent paradigm and EEG decoder that copes with this issue, which will be tested on patients using the Zeto EEG headset.

The Far-North Remote Online Zeto Electroencephalography (F.R.O.Z.E.) Trial by Marcus C. Ng, MD from University of Manitoba, Canada

The FROZE Trial will use Zeto EEG in an emergency room in the far north of the Canadian Arctic for use by everyday clinicians backed by remote interpretation by board-certified epileptologists. This trial will determine how effectively the Zeto platform could improve patient care in even the remotest regions of the Earth.

“We are happy to support the winners of the Clinical Trial Sponsorship program and to see the advantages of Zeto’s dry EEG headset in action. Its ease of use, comfort, and ability to bring EEG out of the lab and into the medical research environment provide significant benefits to researchers in projects such as these,” said A. Mark Mento, Director of Enterprise Sales at Zeto.

Zeto will provide each clinical trial with its FDA cleared products, including up to two headsets per trial along with electrode supplies for up to 100 patients, accompanied by on-site training and ongoing product support. Trials are set to start before the end of 2024 with an anticipated duration ranging between 6 to 12 months.

About Zeto, Inc.

Zeto, Inc., an award-winning medical technology firm, is at the forefront of advancing EEG brain monitoring and diagnostics for healthcare.
Zeto’s revolutionary FDA-cleared EEG platform brings the traditional EEG procedure to the 21st century by offering a zero-prep, wireless, easy-to-wear, portable headsets with active, dry electrodes that can be positioned as per the 10-20 system.
The company plans to leverage its platform technology to improve access and quality to medical EEG testing and to enable and improve adjacent biomedical research and clinical trials.

To learn more about Zeto’s products, please visit https://zeto-inc.com or email us at research@zetoinc.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/zeto-announces-winners-of-clinical-trial-sponsorship-program-302181053.html

SOURCE Zeto, Inc.

Related Topics:
Continue Reading

Technology

STEPHEN A. SMITH ADDRESSES WHITE HOUSE DINNER ATTENDANCE, REAFFIRMS COMMITMENT TO HBCUs AND PROTECTING CORPORATE INVESTMENT IN BLACK EDUCATION

Published

33 minutes ago

on

October 24, 2026

By

NEW YORK, Oct. 23, 2026 /PRNewswire/ — Stephen A. Smith, media mogul, New York Times bestselling author, and proud 1991 graduate of Winston-Salem State University, is addressing the public discussion surrounding his decision to attend a White House dinner with President Donald Trump, emphasizing his commitment to the long-term financial stability of Historically Black Colleges and Universities (HBCUs).

For Smith, the decision was rooted in a commitment to institutions that have educated generations of Black leaders, professionals, entrepreneurs, and public servants.

“I will always advocate for HBCUs and the students whose futures depend on them,” Smith said. “My reason for attending the White House dinner was to discuss the challenges these institutions face in securing long-term funding and to make the case that corporate America must continue to invest in them.”

Smith acknowledged federal support through the FUTURE Act while expressing concern that political tensions surrounding diversity, equity, and inclusion (DEI) could discourage private companies from supporting HBCUs. He maintains that these institutions deserve sustained corporate partnerships, philanthropic contributions, and public investment.

“If we truly believe in free-market capitalism, businesses should be able to support educational institutions and charitable causes without fear of criticism or repercussions,” Smith said. “HBCUs have made extraordinary contributions to this country. They deserve sustained public and private investment.”

Ashley Christopher, Esq., Founder and CEO of the HBCU Week Foundation, recognized Smith’s advocacy and decision to engage with the administration.

“Stephen A. Smith has been a powerful advocate for HBCUs, using his platform and influence to shine a national spotlight on our institutions,” expressed Christopher, “His continued support of HBCU Week helps advance our mission of connecting students with life-changing educational opportunities, and we are proud to have him as our ambassador.”

Since Smith became an HBCU Week Ambassador in 2019, the initiative has facilitated more than 15,000 on-the-spot college acceptances and raised and awarded more than $150 million in scholarships, according to the HBCU Week Foundation.

As public discussion continues, Smith is emphasizing the importance of ensuring HBCUs have the resources and partnerships needed to educate future generations and expand opportunities for students.

CLICK HERE to watch Smith’s full response to his White House visit.

MEDIA CONTACT:

media@mrsasinc.com

View original content:https://www.prnewswire.com/news-releases/stephen-a-smith-addresses-white-house-dinner-attendance-reaffirms-commitment-to-hbcus-and-protecting-corporate-investment-in-black-education-302918547.html

SOURCE Straight Shooter Media

Continue Reading

Technology

Advantex Announces Completion of Financing and Extension of Maturity Date of Previously Issued Debentures

Published

33 minutes ago

on

October 24, 2026

By

TORONTO, Oct. 23, 2026 /CNW/ — Advantex Marketing International Inc. (CSE: ADX) (“Advantex”), a leader in the merchant cash advance and loyalty marketing products for merchants, today announced the completion of a $250,000 secured debt financing. Advantex issued a $250,000 non-convertible debenture which bears an interest rate at 12% per annum and matures December 15, 2027. The proceeds raised from this issuance of the Debenture will be used for working capital purposes.

Advantex has also extended the maturity of its existing $700,000 in 12% secured debentures from October 10, 2026 to December 15, 2027.

About Advantex Marketing International Inc.

Advantex provides working capital to merchants. Advantex also provides specialized marketing programs that enable members of Aeroplan to earn Aeroplan points at participating merchants.

Advantex shares trade on the Canadian Securities Exchange under the symbol ADX. For more information go to Advantex’s profile on www.sedar.com

Forward-Looking Information

This news release contains “forward-looking statements” within the meaning of applicable securities laws relating to the future business and operations of Advantex. Actual results and developments may differ materially from those contemplated by these statements. The business and operations of Advantex described herein is dependent on a number of factors and is subject to a number of risks and uncertainties. Factors that could cause actual results to differ material include, but are not limited to, changes in Advantex’s economic and competitive conditions including but not limited to the industry sectors in which Advantex operates.

The statements in this news release are made of the date of this release. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and Advantex undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable law.

SOURCE Advantex Marketing International Inc.

Continue Reading

Technology

Club Offers for Travel Enthusiasts in Canada

Published

2 hours ago

on

October 23, 2026

By

TORONTO, Oct 23, 2026 /PRNewswire/ — Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, announces three of many new Club Offers for Club Members in Canada.

Rigorously vetted and negotiated for us travel enthusiasts:

$799—COSTA RICA WEEK WITH FLIGHTS & CAR
We think fall is an ideal time to visit Costa Rica; the scenery is lush and the crowds are gone. Drive between volcanic Arenal and the idyllic beaches of Tamarindo on this seven-night trip. Since it’s not as busy, we were able to negotiate a price that saves members up to $648 on departures through mid-December.

$899—BARCELONA: 5 NIGHTS WITH FLIGHTS
Explore Barcelona’s world-class museums and architectural masterpieces in the quieter winter months to pack more into your trip. You won’t waste hours in lines and can access top restaurants that are fully booked in summer. We save $300 on travel this January and February, when temperatures are still spring-like. Roundtrip flights from Toronto, hotel and daily breakfast are included.

$999—ST. KITTS GETAWAY FOR 2, REG. $2083
Most visitors to St. Kitts book months in advance, but when we pointed out that travel enthusiasts are more spontaneous, this resort gave us a terrific rate for stays this November and December. Spend four nights in Frigate Bay and get an upgraded Oceanview room, too.

Are you a travel enthusiast? Join the club today: https://travelzoo.com

Who are we?
We, Travelzoo®, are the club for travel enthusiasts. We reach 30 million travellers. Club Members receive Club Offers negotiated and rigorously vetted by our deal experts around the globe. Our relationships with thousands of top travel companies give us access to irresistible deals. Our club and its benefits are built around the lifestyle of a modern travel enthusiast.

Media Contact: 
Amanda Ieraci – Toronto
+1 437 866 8540
aieraci@travelzoo.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/club-offers-for-travel-enthusiasts-in-canada-302918543.html

SOURCE Travelzoo

Continue Reading

Trending